Cargando…
Targeted therapies for cancer during the COVID-19 pandemic: a threat or a blessing?
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286355/ https://www.ncbi.nlm.nih.gov/pubmed/32517540 http://dx.doi.org/10.2217/pgs-2020-0059 |
_version_ | 1783544863439978496 |
---|---|
author | Moujaess, Elissar Kourie, Hampig Raphael Kattan, Joseph |
author_facet | Moujaess, Elissar Kourie, Hampig Raphael Kattan, Joseph |
author_sort | Moujaess, Elissar |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7286355 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Future Medicine Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-72863552020-06-10 Targeted therapies for cancer during the COVID-19 pandemic: a threat or a blessing? Moujaess, Elissar Kourie, Hampig Raphael Kattan, Joseph Pharmacogenomics Editorial Future Medicine Ltd 2020-06-10 2020-05 /pmc/articles/PMC7286355/ /pubmed/32517540 http://dx.doi.org/10.2217/pgs-2020-0059 Text en © 2020 Future Medicine Ltd This work is licensed under the Creative Commons Attribution 4.0 License (http://creativecommons.org/licenses/by/4.0/) |
spellingShingle | Editorial Moujaess, Elissar Kourie, Hampig Raphael Kattan, Joseph Targeted therapies for cancer during the COVID-19 pandemic: a threat or a blessing? |
title | Targeted therapies for cancer during the COVID-19 pandemic: a threat or a blessing? |
title_full | Targeted therapies for cancer during the COVID-19 pandemic: a threat or a blessing? |
title_fullStr | Targeted therapies for cancer during the COVID-19 pandemic: a threat or a blessing? |
title_full_unstemmed | Targeted therapies for cancer during the COVID-19 pandemic: a threat or a blessing? |
title_short | Targeted therapies for cancer during the COVID-19 pandemic: a threat or a blessing? |
title_sort | targeted therapies for cancer during the covid-19 pandemic: a threat or a blessing? |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286355/ https://www.ncbi.nlm.nih.gov/pubmed/32517540 http://dx.doi.org/10.2217/pgs-2020-0059 |
work_keys_str_mv | AT moujaesselissar targetedtherapiesforcancerduringthecovid19pandemicathreatorablessing AT kouriehampigraphael targetedtherapiesforcancerduringthecovid19pandemicathreatorablessing AT kattanjoseph targetedtherapiesforcancerduringthecovid19pandemicathreatorablessing |